Eosinophil development and bone marrow and tissue eosinophils in atopic asthma

Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):98-100. doi: 10.1159/000024039.

Abstract

Background: Eosinophils develop from bone marrow (BM) progenitors, and interleukin-5 (IL-5) and eotaxin may act in expansion and mobilisation of BM eosinophils in asthma.

Methods: We have examined phenotypic changes as CD34+ cells develop to the eosinophil lineage in vitro, and have evaluated BM eosinophils from asthmatic and control subjects for expression of the eotaxin receptor, CCR3.

Results: Acquisition of receptors for IL-5 and CCR3 was an early event in eosinophil development. There were increased CD34+ cells, and mature and immature CCR3+ eosinophils in BM from asthmatics.

Conclusion: These data suggest that IL-5 may act early in eosinophil development, and that eotaxin has the capacity to mobilise a BM eosinophil pool in asthma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34
  • Asthma / immunology*
  • Asthma / pathology
  • Bone Marrow Cells / immunology*
  • Cell Differentiation / immunology
  • Cells, Cultured
  • Chemokine CCL11
  • Chemokines, CC*
  • Cytokines / immunology
  • Eosinophils / immunology*
  • Eosinophils / pathology
  • Humans
  • Interleukin-5 / immunology
  • Receptors, CCR3
  • Receptors, Chemokine / immunology
  • Receptors, Interleukin / immunology
  • Receptors, Interleukin-5

Substances

  • Antigens, CD34
  • CCL11 protein, human
  • CCR3 protein, human
  • Chemokine CCL11
  • Chemokines, CC
  • Cytokines
  • Interleukin-5
  • Receptors, CCR3
  • Receptors, Chemokine
  • Receptors, Interleukin
  • Receptors, Interleukin-5